Use of tyrosine kinase inhibitors during pregnancy for oncogenic-driven advanced non-small cell lung carcinoma
Anne‐Sophie Boudy, Noémie Grausz, Lise Selleret, Joseph Gligorov, Isabelle Thomassin‐Naggara, Cyril Touboul, Émile Daraï, J. Cadranel
Topics & Concepts
MedicinePregnancyLung cancerTyrosine-kinase inhibitorOncologyPopulationOsimertinibTrastuzumabCancerFetusInternal medicineObstetricsAdenocarcinomaBreast cancerGeneticsBiologyEnvironmental healthROS1Cancer Risks and FactorsOvarian cancer diagnosis and treatmentReproductive Biology and Fertility